SkinAware transforms skin cancer detection to overcome barriers to life‑saving screening. Our smartphone app delivers dermatologist‑level insights at population scale — affordable, accessible, and equitable.
Initial launch: free of charge to spread the word about our mission. No dermoscopy required.
Change the paradigm of melanoma detection with an accessible, validated AI platform designed for FDA 510(k) clearance and payer adoption.
Bridge gaps where specialist access is limited — no dermoscopy required; only a smartphone camera.
High sensitivity and strong specificity aligned to clinical screening needs; configurable thresholds by use‑case.
Faster risk stratification enables earlier excision and improved outcomes while conserving specialty resources.
A shortage of dermatologists and long wait times delay melanoma diagnoses. AI trained on large high‑quality datasets can recognize patterns at scale — offering timely, equitable support for patients and clinicians.
SkinAware shortens the time from lesion detection to cure by empowering individuals with instant risk awareness—helping transform months of waiting into actionable care.
Smartphone‑based AI that captures a lesion photo + key metadata and returns a calibrated risk score (0.0–1.0) to support triage and decision‑making.
Capture lesion photo + basic info (age, location, sex) with privacy‑first handling.
Segmentation → feature extraction → tabular pipeline → feature fusion → ensemble predictions → weighted aggregation.
Probability score indicating estimated likelihood of malignancy, tuned per clinical validation and workflow needs.
Early validation across 217,000+ samples demonstrates strong diagnostic performance (AUC 0.943; pAUC 0.157), balancing life‑saving sensitivity with practical specificity.
Founder & CEO. General surgeon and veteran leading mission‑driven AI innovation in melanoma detection.
Co‑Founder & COO. Public health operator driving equitable access and scalable implementation.
Epidemiology & Biostatistics. Assists with study design, validation strategy, and outcomes analysis.
SkinAware’s mission is strengthened by our work with developer Neocoast and upcoming collaboration efforts with
MD Anderson Cancer Center and University of Kansas Dermatology to advance our research and public health mission.
We have also partnered with Social Good Fund to form the SkinAware Foundation.
We are actively seeking additional team members and partners to help us change the paradigm of skin cancer detection. Please contact us for more information.
We’re launching initially free of charge to broaden access and collect feedback. Get updates and beta invites:
Email: skinawarefounder@gmail.com
LinkedIn: linkedin.com/company/skinaware
SkinAware, Inc. — Public Benefit Corporation
Tax‑deductible gifts may be made via our fiscal sponsor (SkinAware Foundation at Social Good Fund) to support public‑health research and equitable access.
Donate (Link Coming Soon)We will recognize donors on our website.
SkinAware